Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

TRENDING TOPICS:

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Tuesday, Jul 2 2024

Full Issue

Potassium Chloride Capsules Recalled For Irregular Heartbeat Risk

Included in the voluntary recall are 114 batches of Glenmark Pharmaceuticals extended-release capsules. In other news: Only 18% of eligible Americans are up to date on lung cancer screenings; hoarding disorder rises; an anti-noise advocacy group sues the EPA; and more.

WGCU: Potassium Chloride Capsules Recalled For Potentially Deadly Medical Risk

Glenmark Pharmaceuticals is voluntarily recalling 114 batches of potassium chloride extended-release capsules because of failed dissolution. Information from the Mahwah, N.J., company posted on the PR Newswire said the failed dissolution of the capsules may cause high potassium levels, also known as hyperkalemia, which can result in irregular heart beat that can lead to cardiac arrest. (7/1)

The Washington Post: Fewer Than 1 In 5 Eligible Americans Up To Date With Lung Cancer Screenings

Only about 18 percent of eligible Americans were up to date with their lung cancer screenings in 2022, with compliance rates varying by state and region, according to a study published in JAMA Internal Medicine. American Cancer Society researchers analyzed data from the 2022 Behavioral Risk Factor Surveillance System, a population-based, nationwide survey of Americans. (Docter-Loeb, 7/1)

Axios: Hoarding Concerns Rise As America Ages

The rise in hoarding disorder as America ages requires a national response, a new Senate report shared first with Axios says. The prevalence and severity of hoarding disorder increases with age — and the U.S. population is growing older, making this a crucial moment for policymakers to address the condition. (Goldman, 7/2)

NPR: Advocates Are Suing The EPA To Enforce Noise Pollution Law

Last June, an anti-noise advocacy group, Quiet Communities, sued the Environmental Protection Agency for not doing its job to limit the loud sounds people are exposed to in everyday life. The group is now waiting to hear if it will be able to argue its case in front of the U.S. District Court for the District of Columbia. If the judge ultimately rules in the group’s favor, the EPA will have to do what Congress told it to do more than half a century ago, when it passed the Noise Control Act: protect public health and the environment from harmful noise pollution. (Silberner, 7/1)

Stat: Prosthetic Leg Performance Enhanced By Electrode-Implant Surgery

A novel surgical technique could dramatically improve walking for people with below-the-knee amputations and help them better control their prosthetics. A study published Monday in Nature Medicine showed that trial participants who received the procedure could walk faster, were more stable on uneven terrain, and had an increased spatial awareness, or proprioception, in their residual limb. Phantom pain in their limbs lessened, too. (Broderick, 7/1)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, April 24
  • Thursday, April 23
  • Wednesday, April 22
  • Tuesday, April 21
  • Monday, April 20
  • Friday, April 17
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF